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1. Introduction 
Two lipid-containing bacterial viruses, PM2 
[l-3] and 46 [4-61 have been studied in recent 
years as model systems for investigating the 
structure and assembly of biological membranes, 
virus envelopes in particular. One difficulty with 
each of these systems is due to the host bacteria, 
Pseudomonas BAL-3 1 for PM2 and Pseudomonas 
phaseoZicola HBIOY for #6: namely, neither of 
these species can be manipulated genetically nearly 
as well as Escherichia coli. Recently, Bradley and 
Rutherford [7] reported the preliminary characteriza- 
tion of a bacteriophage which can infect E. coli cells 
which carry an appropriate drug-resistance plasmid. 
This bacteriophage, PR4, was presumed to contain 
lipid based on its buoyant density, its sensitivity to 
chloroform, and its morphology as observed by 
electron microscopy. In this report, we show directly 
that PR4 virions produced from E. coli do contain 
lipid. Specifically, we have determined the phospho- 
lipid composition of PR4 in comparison to that of 
the E. coli host cell. We find that more than half the 
phospholipids of PR4 are due to two species, phospha- 
tidylserine and an unknown phospholipid, which are 
present in only small amounts in E. coli (K 12) CR34. 
2. Materials and methods 
2.1. Routine growth of cells and virus 
Two media were used in the experiments reported 
here. NT medium contains 10 g nutrient broth and 
12.1 g Tris (2-amino-2-(hydroxy-methyl)- 1,3-propa- 
nediol) per liter of distilled water. TGN’ medium 
contains 12.1 g Tris, 1.5 g KCl, 1.5 g NaCl, 0.2 g 
North-Holland Publishing Company - Amsterdam 
MgSOq-7H20, 1 g NHGCl, 5 g glucose, 12 mg KH2P0,, 
75 mg K2HP04, and 20 mg each of leucine, threonine, 
thymidine, and nutrient broth per liter of distilled 
water. Both media are adjusted to pH 7.6 by addition 
of HCl. 
Escherichia coli CR34 was routinely grown in 
either NT or TGN’ medium with aeration at 37°C. 
Bacteriophage PR4 lysates were produced by infecting 
cell cultures of 10’ cells/ml with virus at a multiplicity 
of infection of > 1. Following lysis, cellular debris was 
removed by low speed centrifugation and the resulting 
supernatant was stored at 4°C. 
2.2. Production and purification of labeled virus 
32P-labeled PR4 virions were produced as follows. 
To 100 ml of NT or TGN’ medium, about 3 X IO8 
E. coZi CR34 cells and 300 /*Ci 32P phosphate were 
added and the cells were grown with aeration at 37°C 
for 5 generations to about 10’ cells/ml. At this time, 
about 5 X 10” plaque forming units (PFU) of PR4 
were added and aeration was continued. After lysis 
of the infected cultures, cellular debris was removed 
by low speed centrifugation. 
32P-labeled PR4 virions were purified by several 
rounds of ultracentrifugation. Virions were pelleted 
by centrifuging crude lysates at 20 000 rev/min for 
2 h in an SW27 rotor (the same rotor as used for all 
the purification steps which follow). Virions resus- 
pended from the pellets were layered onto 15%-30% 
linear sucrose gradients (in TGN’ medium) and 
centrifuged at 25 000 rev/min for 75 min. Three-ml 
fractions were collected and assayed for radioactivity. 
The peak fractions were layered onto 30%-60% 
linear sucrose gradients (in TGN’ medium) and 
centrifuged at 27 000 rev/min for 180 min. Three-ml 
fractions again were collected and assayed for radio- 
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activity. Peak fractions of the 3a--60% gradients 
were diluted lo-fold and centrifuged at 20 000 
rev/min for 180 min to pellet the virions. 
2.3. Thin layer chromatographic analysis 
Pellets of purified 32P-labeled PR4 virions and 
CR34 cells (uninfected aliquots removed from the 
main cultures just before infection and incubated 
until after lysis of infected cultures) were resuspended 
in 20 ml chloroform:methanol(2: 1). Lipids were 
extracted by incubation at 25°C for 24 h followed 
by 55°C for 4 h. Subsequent steps were as previously 
described [3,5]. The identities of phospholipid spots 
were identified by chromatography of commercial 
standards. 
2.4. Sources of materials 
Stocks of E. coli CR34, a derivative of strain K12 
containing the drug-resistance plasmid RPl, and 
bacteriophage PR4 from the laboratory of Drs Bradley 
and Rutherford [7] were obtained from Dr W. Snipes, 
Pennsylvania State University, University Park, Pa., 
USA. 32P-phosphate (carrier free, 10 mCi/ml) was 
obtained from Schwarz-Mann, Orangeburg, N.Y., 
USA. Phospholipid standards were purchased from 
Sigma Chemical Co., St. Louis, MO., USA. 
3. Results 
To detect and analyze the phospholipids presumed 
to be present in bacteriophage PR4, we produced 
32P-labeled PR4 stocks by prelabeling E. coli CR34 
for 5 generations, infecting with PR4 in the continued 
presence of 32P harvesting the resulting phage by 
differential cenirifugation, and then purifying the 
labeled virions by velocity sedimentation through 
sucrose gradients. Measurement of unincorporated 
32P in the medium in control experiments showed 
that less the half of the 300 PCi originally added to 
the cell culture had been incorporated by the time 
of harvesting of virus. Thus, the radioactivity deter- 
minations which follow are a valid indication of total 
phospholipid content of cells and virus. 
Centrifugation profiles of PR4 are shown in fig. 1. 
Virions were centrifuged in a 15%-30% linear sucrose 
gradient. Virus particles from the peak fraction collect- 
ed from this gradient were then further purified by 
44 
FRACTION 
Fig.1. Purification of 32P-labeled PR4 virions. (A) 15%-30% 
sucrose gradient sedimentation of virions rcsuspendcd from 
a pellet. (B) 30-60% sucrose gradient sedimentation of the 
peak fraction from the lS%-30% gradient. The peak fraction 
from the second gradient routinely contained greater than 
10’ ’ plaque forming units per ml. SW Materials and methods 
for details. 
centrifugation in a 30%-60% linear sucrose gradient. 
All analyses reported here were conducted on virus 
samples which had been ‘doubly’ purified in this 
manner. 
Lipids were extracted from %P-labeled E. coli 
CR34 cells and doubly purified PR4 virions which 
had been produced in cells of the same strain. Phos- 
pholipid analysis was carried out by thin layer 
chromatography. To determine the identity of the 
various phospholipids detected, co-chromatography 
of phospholipid standards was employed. The 
relative mobilities of various standard phospholipids 
are given in table 1 along with the mobilities of the 
phospholipids extracted from E. coli CR34. Phospha- 
tidylethanolamine (PE), phosphatidylglycerol (PC), 
and cardiolipin (C) account for about 90% of the 
cellular phospholipid. In addition, small amounts 
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Table 1 
Chromatographic mobilitics of phospholipidsa 
Phospholipid Commercial standards 
% 
E. coli CR34 
Phosphatidic acid (PA) 124’ 
Phosphatidylethanolamine (PE) 100 
Phosphatidylglycerol (PC) 85 
Cardiolipin (C) 80 
Phosphatidylserine (PS) 62 
PXb 
a Silica gel plates. Chloroform:methanol:water (65:25:4) solvent. 
b PX: unknown phosphorous-containing lipid. 
c Mobilities measured relative to PE. 
100 
87 
82 
61.5 
25 
(see below) of phosphatidylserine (PS) and an unknown 
phospholipid (PX) are present in this cell. This 
unknown phospholipid might be phosphatidylglycerol- 
phosphate [8] or CDP-diglyceride [9]. 
32P-labeled lipids of E. coli CR34 and bacteriophage 
PR4 separated by thin layer chromatography and 
detected by autoradiography were scraped from the 
TLC plates and counted by liquid scintillation spectro- 
metry to determine the quantitative phospholipid 
composition of the virus and host cell. The results 
are shown in table 2. Bacteriophage PR4 contains PE, 
PG, C, PS, and PX, as does E. coli CR34. Virions 
produced in either growth medium, NT or TGN’, 
contain large amounts of PS and especially PX; 
specifically, these two lipids account for more than 
50% of the lipid phosphorous in the virus. 
As also shown in table 2, the phospholipid 
composition of E. coli CR34 depends on the growth 
Table 2 
Phospholipids of bacteriophage PR4 and it E. coli host 
Organism Growth PE PG c PS PX 
media 
E. coli CR34 NT 57a 30 7 3 3 
TGN+ 37 43 710 3 
Bacteriophage PR4 NT 21 20 6 20 33 
TGN+ 16 23 7 15 39 
a All values given as per cent of total. Estimated accuracy is 
+ 3%. 
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medium, and this difference is reflected somewhat 
in the PR4 virions. 
4. Discussion 
The data presented in this report show that 
bacteriophage PR4, which can infect ~5 coli, does 
indeed contain lipid. In addition, we have shown 
that PR4 has a phospholipid composition that is 
markedly different quantitatively from that of its 
E. coli host cell. 
The lipid-containing bacteriophage PM2 and & 
also have phospholipid compositions different from 
that of their host cells [5, lo]. These phages have 
been shown to alter cellular phospholipid synthesis 
during infection for the apparent purpose of facili- 
tating virus assembly ([3], unpublished data from 
this laboratory). It will not be surprising if a some- 
what similar process occurs in PR4-infected E. coli 
cells. 
The main importance of the existence of bacterio- 
phage PR4 is that it is the only known lipid-contain- 
ing bacterial virus which can productively infect E. 
coli. Many membrane related mutants of E. coli 
exist which could greatly facilitate an investigation 
of the molecular membrane assembly process of PR4. 
As an example, we mention the recent isolation of a 
mutant of E. coli which is temperature sensitive for 
the final step in the synthesis of phosphatidylethanol- 
amine (PS -+ PE) [I 11. This and other mutants could 
become hosts for bacteriophage PR4 by receiving the 
drug resistance plasmid from strain CR34. 
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